Avalyn Pharma Q3 EPS $(0.67) Beats $(0.75) Estimate
Benzinga Newsdesk 5 hours ago
NewsEarningsEarnings Beats
Avalyn Pharma (NASDAQ:AVLN) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.75) by 10.67 percent. This is a 96.71 percent increase over losses of $(20.34) per share from
Avalyn Pharma (NASDAQ:AVLN) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.75) by 10.67 percent. This is a 96.71 percent increase over losses of $(20.34) per share from the same period last year.